Eurofins Discovery
Kevin Thomas has a diverse work experience in the scientific and pharmaceutical fields. Kevin started their career at Pfizer as a Statistical Quality Assurance Analyst, ensuring compliance with regulatory organizations. Kevin then joined the American Red Cross as an Immunohematology Laboratory Technologist, where they conducted testing and analysis of blood samples and managed projects. Currently, they are working at Eurofins Discovery, progressing from an ADME-Toxicology Associate Scientist to a Study Director II/Principal Scientist, specializing in ADMET and ADME-Toxicology studies. Throughout their roles, Kevin has gained expertise in laboratory supervision, data management, and quality control.
Kevin Thomas completed their Bachelor of Science in Biological Sciences from the University of Missouri-Columbia, specializing in Biology/Life Sciences, from 2009 to 2012. Currently, they are pursuing a Master of Science degree in Drug Discovery and Development from Drexel University, which started in 2022 and is expected to be completed in 2025.
This person is not in any offices
Eurofins Discovery
Eurofins Discovery has supported Drug Discovery research for >40 years. Our partners inspire us to innovate in the pursuit of life-changing cures. We provide our experience, depth, and breadth in the form of innovative testing services and product tools that support researchers as they accelerate the discovery and development of candidate molecules. Our global team of dedicated scientists, information analysts, and client support professionals make this mission possible. Our focus drives us to continually expand our portfolio of testing methods, tools, and services to enable real, lasting improvements in human health. Join our dynamic team! View open positions: https://www.eurofinsdiscovery.com/about-us